Ipilimumab vs Zolpidem
Ipilimumab vs Zolpidem: Overview
This comparison examines the pharmacological differences between Ipilimumab and Zolpidem.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Zolpidem: Selective GABA-A receptor alpha-1 subunit agonist.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Zolpidem — 2.5 hours.
Chemical Properties
Molecular Formula: Zolpidem — C19H21N3O.
Molecular Weight: Zolpidem — 307.3950 g/mol.
Type: Ipilimumab — Antibody; Zolpidem — Small molecule.